Zobrazeno 1 - 4
of 4
pro vyhledávání: '"протипухлинна хіміотерапія"'
Autor:
V. A. Bacherikov
Publikováno v:
Vìsnik Odesʹkogo Nacìonalʹnogo Unìversitetu: Hìmìâ, Vol 18, Iss 4(48), Pp 26-33 (2015)
In the review the structure of the basic antifolate antagonists, their intracellular enzyme tar-gets, and their mechanisms of antitumor activity were considered. Folate antimetabolites, which were discovered in the last decade and trends in finding p
Externí odkaz:
https://doaj.org/article/8430b14bdbb941a0aeb0f88735679f17
Autor:
V. A. Bacherikov
Publikováno v:
Vìsnik Odesʹkogo Nacìonalʹnogo Unìversitetu: Hìmìâ, Vol 18, Iss 3(47), Pp 38-52 (2014)
In the review the structure of the basic antifolate antagonists, their intracellular enzyme targets, and their mechanisms of antitumor activity were considered. Folate antimetabolites, which were discovered in the last decade and trends in finding po
Externí odkaz:
https://doaj.org/article/2956ecb636914028940ca1d9acdc293c
Autor:
Samusieva, A.A., Zotov, A.S.
Publikováno v:
Practical oncology; Том 2, № 1 (2019); 26-29
Практическая онкология-Praktična onkologìâ; Том 2, № 1 (2019); 26-29
Практична онкологія-Praktična onkologìâ; Том 2, № 1 (2019); 26-29
Практическая онкология-Praktična onkologìâ; Том 2, № 1 (2019); 26-29
Практична онкологія-Praktična onkologìâ; Том 2, № 1 (2019); 26-29
Chemotherapy is an important and inalienable method of treatment in oncology, errors in which is a serious problem. These errors depend on many organizational, technical and administrative factors, the main of them will be discussed in this article
Autor:
Bacherikov, V. A.
Publikováno v:
Odesa National University Herald. Chemistry; Том 18, № 3(47) (2013); 38-52
Вестник Одесского национального университета. Химия; Том 18, № 3(47) (2013); 38-52
Вісник Одеського національного університету. Хімія; Том 18, № 3(47) (2013); 38-52
Вестник Одесского национального университета. Химия; Том 18, № 3(47) (2013); 38-52
Вісник Одеського національного університету. Хімія; Том 18, № 3(47) (2013); 38-52
In the review the structure of the basic antifolate antagonists, their intracellular enzyme targets, and their mechanisms of antitumor activity were considered. Folate antimetabolites, which were discovered in the last decade and trends in finding po